SCHEMBL13703228

SCHEMBL13703228

CNCC(=O)c1ccc(CC(N)C(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 5/20 0.56
▸ TPH1 P17752 4/20 0.55
▸ PTGS1 P23219 3/20 0.54
▸ ALPI P09923 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ XIAP P98170 1/20 0.54
▸ GRB2 P62993 1/20 0.48
▸ ALOX15 P16050 3/20 0.47
▸ HIF1A Q16665 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ EGFR P00533 1/20 0.47
▸ LCK P06239 1/20 0.47
▸ FYN P06241 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47
▸ HTR2A P28223 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8228860 0.86 SLC7A5 (0.57) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL456271 0.84 SLC7A5 (0.59) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL456272 0.84 SLC7A5 (0.59) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL8228828 0.82 TPH1 (0.54) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL12641443 0.82 SLC7A5 (0.61) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL28920920 0.82 SLC7A5 (0.61) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL5547492 0.81 SLC7A5 (0.68) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL16577961 0.80 SLC7A5 (0.62) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL12611747 0.80 SLC7A5 (0.62) SLC7A5TPH1PTGS1ALPIPKM
SCHEMBL384961 0.80 SLC7A5 (0.62) SLC7A5TPH1PTGS1ALPIPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090240029-A1 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides AMBRX, INC. (US) 2009-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240029-A1 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides DNPEP, DDC, PTMS SLC7A5 409/4885TPH1 3747/4885PTGS1 3564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback